key: cord-0729116-g4ehxxog
authors: Bongiovanni, Marco
title: COVID‐19 re‐infection in an healthcare worker
date: 2020-09-29
journal: J Med Virol
DOI: 10.1002/jmv.26565
sha: b8e762ccac312da5ba7a512c5321646e1cde2a46
doc_id: 729116
cord_uid: g4ehxxog

The paper by Kang et al. (1) that has been recently published into your journal evaluated a very important topic for the management of COVID‐19 infection as the clinical meaning of being re‐tested positive in subjects recovered from COVID‐19 pneumonia. This article is protected by copyright. All rights reserved.

The paper by Kang et al. (1) that has been recently published into your journal evaluated a very important topic for the management of COVID-19 infection as the clinical meaning of being re-tested positive in subjects recovered from COVID-19 pneumonia. In particular, it remains still unclear the risk of convalescing patients to have a re-infection by COVID-19; at the very beginning of pandemic, a study on SARS-CoV-2 infected monkeys seemed to ruled out the risk of re-infection (2) . Nevertheless, some other case series in humans suggested a very reliable possibility of re-infection (3) (4) (5) . As a consequence, at the moment there are not enough data to definitively settle the question. We describe here the case of a nurse with positive RT-PCR and serological tests, followed-up by 4 consecutive negative nasopharyngeal swabs who, after another exposure to COVID-19, presented another RT-PCR test positive and had a significant increase of antibody anti SARS-CoV-2 titer.

A 48 years old nurse underwent to nasopharyngeal swab RNA test for SARS-CoV-2 at March 9 th for the development of dry cough and mild fever, without other signs of respiratory failure (arterial oxygen saturation was 99% and breath frequency was 15/minute). She hadn't any chronic disease and did not receive any chronic medication at that time. Nasopharyngeal swab test was positive and, according to WHO guidelines, the patient was quarantined. Nasopharyngeal tests got negative (2 consecutive negative tests repeated after 24-48 hours from each other) at March 31 th ; a serological test was also performed and showed antibody titer of 48 Au/mL (normal values < 12 Au/mL). Serological test was performed using the LIASON ® SARS-CoV-2 S1/S2 IgG test that provides a quantitative assay for the detection of IgG antibodies against S1/S2 antigens of SARS-CoV2.

At April 20 th and 22 th the patient was tested again because she was hired in another hospital. Nasopharyngeal swabs were still negative and serological test showed antibody titer of 30 Au/mL. At June 29 th she was exposed to SARS-CoV-2 for caring for a patient who accidentally discovered to be positive (this patient was admitted at Emergency Department for lipothymia and had never had respiratory or gastrointestinal symptoms or fever or anosmia/dysgeusia). A nasopharyngeal swab was then repeated and resulted positive; as a consequence, she was forced to another quarantine period. At that moment, she was completely asymptomatic. Nasopharyngeal swab tests got negative at July 30 th and August 1 st ; at July 30 th a serological test was repeated and showed an antibody titer of 102.9 Au/mL, suggesting a possible re-infection rather than a recurrence or a persistence of COVID-19 infection due to viral shedding.

A the moment, nasopharyngeal swab RT-PCR remains the gold standard to diagnose and manage COVID-19 infection. However, an amount of false negative results have been reported, mainly due to sampling procedures, sources of samples and the sensitivity/specificity of the nucleic acid test kit (6) . As a consequence, when asymptomatic subjects are tested it is extremely difficult to discriminate between recurrence of COVID-19 infection or intermittent shedding of RNA fragments or new onset infections. In particular, it could be possible that recurrences should be persistent infections in which nasopharyngeal swab resulted falsely negative at discharge, and that truly negative patients suffered reactivation or are re-infected with another COVID-19 strain, especially if co-morbidities are present (3) . In the case we present, the patient maintained always clinically asymptomatic and has been repeatedly tested for COVID-19 infection only because she is an healthcare worker. In this specific case, the significant increase of antibody titer when she was discovered to be COVID-19 infected for the second time makes the possibility of a re-infection plausible. This finding may suggest that a periodic evaluation of the antibody titer could be useful in the management of COVID-19 infection, especially in high-risk subjects as the healthcare workers.

Retest positive for SARS-Cov-2 RNA of "recovered" patients with COVID-19: persistence, sampling issues, or reinfection

Reinfection could not occur in SARS-CoV-2 infected rhesus macaques

The dilemma of COVID-19 recurrence after clinical recovery

Clinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound?

Clinical features of COVID-19 convalescent patients with re-positive nucleic acid detection

False negative rate of COVID-19 is eliminated by using nasal swab test